Biogen, Pharmacia & Upjohn metabolic news

BGEN and Harvard University filed suit in Sweden against Pharmacia & Upjohn, alleging that the pharma company's sale of its Genotropin human growth hormone violates their patent covering the secretion of human growth hormone. The product, which was introduced in Europe in 1987, had worldwide sales of $370 million in 1994. ...